The common gut bacterium Escherichia coli thrives in the environment of the intestines, but skin seems to be too much for the bugs to handle. In the January 2005 issue of Nature Immunology, researchers report the identification of an antimicrobial protein secreted by the skin, called psoriasin, that preferentially kills E. coli - making this molecule important in protecting healthy skin and possibly other body surfaces from E. coli infection. Certain microbes can colonize the skin, whereas others are rapidly killed. Jens-Michael Schröder and colleagues observed that E. coli cannot grow on fingertips. They collected the wastewater from skin washings and identified the killer of E. coli as a protein already called psoriasin, which was previously associated with breast and other cancers. They show that psoriasin kills several strains of E. coli by mopping up zinc, which is required for bacterial survival. By analyzing several locations of the body, the authors conclude that psoriasin is particularly abundant in areas exposed to high densities of E. coli. Hence, psoriasin is cleverly ready and waiting, like a set trap, to selectively target a potentially pathogenic bacterium.
Jens-Michael Schröeder (University-Hospital Schleswig Holstein, Kiel, Germany)
Tel: +49 431 597 1536, E-mail: email@example.com
Additional contact for comment on paper:
Charles L. Bevins (University of California at Davis, CA, USA)
Tel: +1 530 754 6889, E-mail: firstname.lastname@example.org
Also published online.
(C) Nature Immunology press release.
Message posted by: Trevor M. D'Souza
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...